Fate Therapeutics opens for trade at $6.56, IPO priced at $6.00

theflyonthewall.com

Fate Therapeutics (FATE) priced 6.778M shares at $6.00. Cowen and BMO Capital acted as joint book running managers for the offering.

View Comments (0)